Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustrySystems Software
SectorComputer and Technology
SymbolNASDAQ:IMPV
CUSIP45321L10
Phone650-345-9000
Debt
Debt-to-Equity RatioN/A
Current Ratio2.68
Quick Ratio2.68
Price-To-Earnings
Trailing P/E Ratio-162.14
Forward P/E Ratio-39.48
P/E GrowthN/A
Sales & Book Value
Annual Sales$321.72 million
Price / Sales4.90
Cash Flow$0.0559 per share
Price / Cash811.90
Book Value$9.26 per share
Price / Book4.90
Profitability
EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Net Margins-8.59%
Return on Equity-6.92%
Return on Assets-4.09%
Miscellaneous
Employees1,020
Outstanding Shares34,690,000
Market Cap$1.58 billion
Imperva (NASDAQ:IMPV) Frequently Asked Questions
What is Imperva's stock symbol?
Imperva trades on the NASDAQ under the ticker symbol "IMPV."
How were Imperva's earnings last quarter?
Imperva Inc (NASDAQ:IMPV) issued its quarterly earnings results on Thursday, July, 26th. The software maker reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.07. The software maker had revenue of $84.80 million for the quarter, compared to analysts' expectations of $87.22 million. Imperva had a negative net margin of 8.59% and a negative return on equity of 6.92%. Imperva's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.24 earnings per share. View Imperva's Earnings History.
When is Imperva's next earnings date?
What price target have analysts set for IMPV?
16 brokers have issued 12-month price targets for Imperva's shares. Their forecasts range from $39.00 to $70.00. On average, they anticipate Imperva's share price to reach $54.0909 in the next twelve months. This suggests a possible upside of 19.1% from the stock's current price. View Analyst Price Targets for Imperva.
What is the consensus analysts' recommendation for Imperva?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Imperva in the last year. There are currently 2 sell ratings, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Imperva.
What are Wall Street analysts saying about Imperva stock?
Here are some recent quotes from research analysts about Imperva stock:
- 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (8/14/2018)
- 2. BTIG Research analysts commented, "Imperva posted a strong beat on Non-GAAP EPS, a moderate beat on revenues, and weaker than expected billings, deferred revenues, operating margin and cash flows. Disruptions in the North American salesforce during the quarter seems to have created challenges in delivering the results. While Asia Pacific seems to have been off to a strong start, with Europe following, without the North America engine in full throttle, Imperva cannot get to its destination. We like management’s vision to transform into a hybrid cybersecurity leader, but until we see tangible outcomes, we are forced to remain on the sidelines. Maintain Neutral." (4/29/2018)
Who are some of Imperva's key competitors?
Some companies that are related to Imperva include National Instruments (NATI), Okta (OKTA), MuleSoft (MULE), Konami (KNMCY), New Relic (NEWR), RealPage (RP), BlackBerry (BB), SINA (SINA), HubSpot (HUBS), Nuance Communications (NUAN), Blackbaud (BLKB), Ceridian HCM (CDAY), Medidata Solutions (MDSO), 2U (TWOU) and LogMeIn (LOGM).
Who are Imperva's key executives?
Imperva's management team includes the folowing people:
- Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
- Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
- Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
- Mr. Aharon Strosberg, VP of Operations
- Mr. Terry Ray, Chief Technology Officer
Has Imperva been receiving favorable news coverage?
News stories about IMPV stock have trended somewhat positive on Tuesday, Accern reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Imperva earned a coverage optimism score of 0.13 on Accern's scale. They also assigned news coverage about the software maker an impact score of 47.96 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Imperva.
Who are Imperva's major shareholders?
Imperva's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.81%), RGM Capital LLC (5.12%), Renaissance Technologies LLC (2.84%), Eagle Asset Management Inc. (2.57%), Carillon Tower Advisers Inc. (2.27%) and Rothschild Asset Management Inc. (1.71%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.
Which institutional investors are selling Imperva stock?
IMPV stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Millennium Management LLC, Carillon Tower Advisers Inc., Segall Bryant & Hamill LLC, North Run Capital LP, American Century Companies Inc., Point72 Asset Management L.P. and Spark Investment Management LLC. Company insiders that have sold Imperva company stock in the last year include Anthony J Bettencourt and Michael D Mooney. View Insider Buying and Selling for Imperva.
Which institutional investors are buying Imperva stock?
IMPV stock was purchased by a variety of institutional investors in the last quarter, including Thompson Siegel & Walmsley LLC, First Trust Advisors LP, Legal & General Group Plc, Cambiar Investors LLC, Rothschild Asset Management Inc., Emerald Advisers Inc. PA, BlackRock Inc. and Emerald Mutual Fund Advisers Trust. View Insider Buying and Selling for Imperva.
How do I buy shares of Imperva?
Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Imperva's stock price today?
One share of IMPV stock can currently be purchased for approximately $45.40.
How big of a company is Imperva?
Imperva has a market capitalization of $1.58 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.
How can I contact Imperva?
Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]
MarketBeat Community Rating for Imperva (NASDAQ IMPV)
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.
